Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCHEDULE Study 5-7 Year Follow-up
NCT02864706Phase 4Completed
- Sponsor
- Novartis
- Start
- Jan 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of everolimus in heart transplantation, sponsored by Novartis. Started Jan 2016; status: completed.
02
Drugs
everolimus
03
Conditions
heart transplantation
Beyond the preview
Go deeper on NCT02864706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02864706.